SLC25A20 and pancreatic neoplasm: Furthermore, immunostaining of pancreatic cancer tissues from each group revealed a 52% decrease in the expression of p-mTOR in tissues from KPC/ Slc25a20+/- mice compared to KPC mice (Figure S11C).